Healthcare & Life Sciences

SoniVie

acquiredseries-c-plus
series-c-plus
Stage
1
Investors

About

SoniVie is a medical device company developing a novel therapeutic solution for patients with pulmonary hypertension. They utilize proprietary renal denervation technology for their treatments.

Explore SoniVie's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.